Monday, September 30, 2019

Ranitidine controversy: Which Indian pharma companies stand to lose?

Ranitidine controversy: Which Indian pharma companies stand to lose? NULL

from Moneycontrol Business News https://ift.tt/2nRJ8ks

No comments:

Post a Comment

Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr

Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operation...